COMPARISON OF BASELINE CHARACTERISTICS AND IMPROVEMENT IN DISEASE MANIFESTATIONS FOLLOWING TREATMENT WITH SEBELIPASE ALFA IN PATIENTS WITH LYSOSOMAL ACID LIPASE DEFICIENCY WITH AND WITHOUT CIRRHOSIS

KN Furuya; F Abel; Elmar Aigner; QM Dong; JQ Bernabeu; V Ratziu; M Zharkova; R Kohli

COMPARISON OF BASELINE CHARACTERISTICS AND IMPROVEMENT IN DISEASE MANIFESTATIONS FOLLOWING TREATMENT WITH SEBELIPASE ALFA IN PATIENTS WITH LYSOSOMAL ACID LIPASE DEFICIENCY WITH AND WITHOUT CIRRHOSIS

KN Furuya, F Abel, Elmar Aigner, QM Dong, JQ Bernabeu, V Ratziu, M Zharkova, R Kohli

Department of Internal Medicine I- Division of Gastroenterology, Hepatology, Nephrology, Metabolism and Diabetologylog

Research output: Contribution to journal › published Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	26A-27A
Journal	HEPATOLOGY
Volume	72
Publication status	Published - 2020
Event	Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) - ELECTR NETWORK Duration: 13 Nov 2020 → 16 Nov 2020

Cite this

Furuya, KN., Abel, F., Aigner, E., Dong, QM., Bernabeu, JQ., Ratziu, V., Zharkova, M., & Kohli, R. (2020). COMPARISON OF BASELINE CHARACTERISTICS AND IMPROVEMENT IN DISEASE MANIFESTATIONS FOLLOWING TREATMENT WITH SEBELIPASE ALFA IN PATIENTS WITH LYSOSOMAL ACID LIPASE DEFICIENCY WITH AND WITHOUT CIRRHOSIS. HEPATOLOGY , 72, 26A-27A.

Furuya, KN ; Abel, F ; Aigner, Elmar et al. / COMPARISON OF BASELINE CHARACTERISTICS AND IMPROVEMENT IN DISEASE MANIFESTATIONS FOLLOWING TREATMENT WITH SEBELIPASE ALFA IN PATIENTS WITH LYSOSOMAL ACID LIPASE DEFICIENCY WITH AND WITHOUT CIRRHOSIS. In: HEPATOLOGY 2020 ; Vol. 72. pp. 26A-27A.

@article{c40064d9f7d44af79c7137df0084caef,

title = "COMPARISON OF BASELINE CHARACTERISTICS AND IMPROVEMENT IN DISEASE MANIFESTATIONS FOLLOWING TREATMENT WITH SEBELIPASE ALFA IN PATIENTS WITH LYSOSOMAL ACID LIPASE DEFICIENCY WITH AND WITHOUT CIRRHOSIS",

author = "KN Furuya and F Abel and Elmar Aigner and QM Dong and JQ Bernabeu and V Ratziu and M Zharkova and R Kohli",

year = "2020",

language = "English",

volume = "72",

pages = "26A--27A",

journal = "HEPATOLOGY ",

issn = "0270-9139",

note = "Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) ; Conference date: 13-11-2020 Through 16-11-2020",

}

Furuya, KN, Abel, F, Aigner, E, Dong, QM, Bernabeu, JQ, Ratziu, V, Zharkova, M & Kohli, R 2020, 'COMPARISON OF BASELINE CHARACTERISTICS AND IMPROVEMENT IN DISEASE MANIFESTATIONS FOLLOWING TREATMENT WITH SEBELIPASE ALFA IN PATIENTS WITH LYSOSOMAL ACID LIPASE DEFICIENCY WITH AND WITHOUT CIRRHOSIS', HEPATOLOGY , vol. 72, pp. 26A-27A.

COMPARISON OF BASELINE CHARACTERISTICS AND IMPROVEMENT IN DISEASE MANIFESTATIONS FOLLOWING TREATMENT WITH SEBELIPASE ALFA IN PATIENTS WITH LYSOSOMAL ACID LIPASE DEFICIENCY WITH AND WITHOUT CIRRHOSIS. / Furuya, KN; Abel, F; Aigner, Elmar et al.
In: HEPATOLOGY , Vol. 72, 2020, p. 26A-27A.

Research output: Contribution to journal › published Abstract (Journal) › peer-review

TY - JOUR

T1 - COMPARISON OF BASELINE CHARACTERISTICS AND IMPROVEMENT IN DISEASE MANIFESTATIONS FOLLOWING TREATMENT WITH SEBELIPASE ALFA IN PATIENTS WITH LYSOSOMAL ACID LIPASE DEFICIENCY WITH AND WITHOUT CIRRHOSIS

AU - Furuya, KN

AU - Abel, F

AU - Aigner, Elmar

AU - Dong, QM

AU - Bernabeu, JQ

AU - Ratziu, V

AU - Zharkova, M

AU - Kohli, R

PY - 2020

Y1 - 2020

M3 - published Abstract (Journal)

SN - 0270-9139

VL - 72

SP - 26A-27A

JO - HEPATOLOGY

JF - HEPATOLOGY

T2 - Liver Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)

Y2 - 13 November 2020 through 16 November 2020

ER -

Furuya KN, Abel F, Aigner E, Dong QM, Bernabeu JQ, Ratziu V et al. COMPARISON OF BASELINE CHARACTERISTICS AND IMPROVEMENT IN DISEASE MANIFESTATIONS FOLLOWING TREATMENT WITH SEBELIPASE ALFA IN PATIENTS WITH LYSOSOMAL ACID LIPASE DEFICIENCY WITH AND WITHOUT CIRRHOSIS. HEPATOLOGY . 2020;72:26A-27A.